HCA(HCA)
HCA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $78.53B | $82.28B | $86.72B | $91.73B | $97.96B |
| Low | $77.00B | $81.44B | $86.64B | $90.36B | $96.49B |
| High | $79.69B | $83.96B | $86.81B | $93.24B | $99.57B |
| EBITDA Avg | $16.68B | $17.48B | $18.42B | $19.49B | $20.81B |
| Low | $16.36B | $17.30B | $18.41B | $19.20B | $20.50B |
| High | $16.93B | $17.84B | $18.44B | $19.81B | $21.15B |
| EBIT Avg | $12.93B | $13.55B | $14.28B | $15.11B | $16.13B |
| Low | $12.68B | $13.41B | $14.27B | $14.88B | $15.89B |
| High | $13.13B | $13.83B | $14.30B | $15.36B | $16.40B |
| Net Income Avg | $6.92B | $7.74B | $8.57B | $9.75B | $11.24B |
| Low | $6.75B | $7.45B | $8.14B | $9.56B | $11.02B |
| High | $7.10B | $8.02B | $9.00B | $9.96B | $11.48B |
| EPS Avg | $30.23 | $33.18 | $37.22 | $42.25 | $48.73 |
| Low | $29.25 | $32.31 | $35.26 | $41.43 | $47.78 |
| High | $30.76 | $34.76 | $39.02 | $43.15 | $49.77 |
| Analysts (Rev / EPS) | 18 / 16 | 18 / 16 | 12 / 9 | 11 / 3 | 6 / 3 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $19.38B | $19.77B | $20.28B | $20.05B | $20.20B | $20.67B | $21.20B | $21.18B |
| Low | $19.26B | $19.56B | $19.80B | $19.57B | $19.72B | $20.17B | $20.70B | $20.68B |
| High | $19.68B | $19.97B | $20.87B | $20.63B | $20.79B | $21.27B | $21.82B | $21.80B |
| EBITDA Avg | $4.12B | $4.20B | $4.31B | $4.26B | $4.29B | $4.39B | $4.50B | $4.50B |
| Low | $4.09B | $4.16B | $4.21B | $4.16B | $4.19B | $4.29B | $4.40B | $4.39B |
| High | $4.18B | $4.24B | $4.43B | $4.38B | $4.42B | $4.52B | $4.64B | $4.63B |
| EBIT Avg | $3.19B | $3.26B | $3.34B | $3.30B | $3.33B | $3.40B | $3.49B | $3.49B |
| Low | $3.17B | $3.22B | $3.26B | $3.22B | $3.25B | $3.32B | $3.41B | $3.41B |
| High | $3.24B | $3.29B | $3.44B | $3.40B | $3.42B | $3.50B | $3.59B | $3.59B |
| Net Income Avg | $1.67B | $1.65B | $1.90B | $1.78B | $1.85B | $1.81B | $2.14B | $1.94B |
| Low | $1.63B | $1.54B | $1.84B | $1.73B | $1.80B | $1.75B | $2.07B | $1.88B |
| High | $1.72B | $1.72B | $1.97B | $1.85B | $1.92B | $1.88B | $2.22B | $2.01B |
| EPS Avg | $7.35 | $7.29 | $8.37 | $7.86 | $8.17 | $7.98 | $9.44 | $8.55 |
| Low | $7.20 | $6.81 | $8.11 | $7.62 | $7.92 | $7.73 | $9.15 | $8.28 |
| High | $7.58 | $7.60 | $8.68 | $8.16 | $8.48 | $8.28 | $9.80 | $8.87 |
| Analysts (Rev / EPS) | 14 / 15 | 15 / 14 | 11 / 10 | 7 / 10 | 7 / 6 | 7 / 7 | 7 / 6 | 6 / 7 |